Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Eugen Kolossov"'
Autor:
Elke Gabriel, Stephanie Schievenbusch, Eugen Kolossov, Jan G Hengstler, Tamara Rotshteyn, Heribert Bohlen, Dirk Nierhoff, Jürgen Hescheler, Irina Drobinskaya
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44912 (2012)
Embryonic stem cell-derived hepatocyte precursor cells represent a promising model for clinical transplantations to diseased livers, as well as for establishment of in vitro systems for drug metabolism and toxicology investigations. This study aimed
Externí odkaz:
https://doaj.org/article/955c0b2c2cd349a79bc40d242d6cdad9
Autor:
Niels Fertig, Eugen Kolossov, Sonja Stoelzle, Alison Haythornthwaite, Heribert Bohlen, Andrea Brüggemann, Michael George, Ralf Kettenhofen
Publikováno v:
SLAS Discovery. 16:910-916
Cardiovascular side effects are critical in drug development and have frequently led to late-stage project terminations or even drug withdrawal from the market. Physiologically relevant and predictive assays for cardiotoxicity are hence strongly dema
Autor:
Irina Drobinskaya, Tomo Saric, Eugen Kolossov, Heribert Bohlen, Jürgen Hescheler, Reinhard G. Bretzel, Thomas Linn
Publikováno v:
Stem Cells. 26:2245-2256
Potential therapeutic applications of embryonic stem cell (ESC)-derived hepatocytes are limited by their relatively low output in differentiating ESC cultures, as well as by the danger of contamination with tumorigenic undifferentiated ESCs. To addre
Publikováno v:
Advanced Drug Delivery Reviews. 60:146-159
Progress in gene therapy has produced promising results that translate experimental research into clinical treatment. Gene modification has been extensively employed in cell transplantation. The main barrier is an effective gene delivery system. Seve
Publikováno v:
Herz. 27:589-597
Cardiomyopathy is characterized by the loss of functional cardiomyocytes resulting in heart failure. More recently, there is increasing evidence from animal studies that transplantation of cardiomyocytes may represent a valuable approach for the trea
Publikováno v:
Toxicology in Vitro. 16:589-597
The capacity of pluripotent embryonic stem cells (ESC) to differentiate in vitro into various tissues provides the opportunity to develop an in vitro assay for investigating mechanisms of developmental toxicity. ESC clones carrying tissue specific re
Autor:
Gottfried Brem, Klaus Tiemann, Klaus Addicks, Ying Xia, Michaela Fleischmann, Wilhelm Bloch, Eva Stoecker, Robert Stehle, Bernd K. Fleischmann, Gabriele Pfitzer, Heribert Bohlen, Eugen Kolossov, Sharon Siedner, Zhong J. Lu, Armin Welz, Wilhelm Roell, Juergen Hescheler
Publikováno v:
Circulation. 105:2435-2441
Background — Cellular cardiomyoplasty is discussed as an alternative therapeutic approach to heart failure. To date, however, the functional characteristics of the transplanted cells, their contribution to heart function, and most importantly, the
Autor:
Axel Raible, Bernd K. Fleischmann, Shohreh Kazemi, Klaus Addicks, Wilhelm Bloch, Daniela Wenzel, Nibedita Lenka, Eugen Kolossov, Philipp Sasse, Juergen Hescheler
Publikováno v:
Cellular Physiology and Biochemistry. 12:55-62
Primary vascular plexus originate from angioblasts through a process called vasculogenesis. The precise role of basic fibroblast growth factor (bFGF) and the vascular endothelial growth factor (VEGF) are both suggested as key regulators in vasculogen
Autor:
Stefan Arnhold, Eugen Kolossov, Franz-Josef Klinz, Christian Andressen, Klaus Addicks, Jürgen Hescheler, Doris Lenartz, Klaus Kruttwig, Volker Sturm
Publikováno v:
Journal of Neurosurgery. 93:1026-1032
Object. The aim of this investigation was to assess new information concerning the capacity of transplanted embryonic stem cell (ESC)-derived neuronal cells to migrate into host brain and to evaluate these cells as a possible source for cell replacem
Autor:
Gottfried Brem, Christian Andressen, Juergen Hescheler, Wilhelm Bloch, Klaus Addicks, Mathias Müller, Eugen Kolossov, Bernd K. Fleischmann, Michaela Fleischmann
Publikováno v:
FEBS Letters. 440:370-376
We demonstrate the establishment of transgenic mice, where the expression of the green fluorescent protein (GFP) is under control of the human cardiac alpha-actin promoter. These mice display cardiac specific GFP expression already during early embry